We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Clinical Trial Compares Stem Cell Transplantation to Currently Available Drugs for MS

News   Jan 07, 2020 | Original story from the National Institutes of Health

 
New Clinical Trial Compares Stem Cell Transplantation to Currently Available Drugs for MS
 
 
Advertisement
 

RELATED ARTICLES

Novel Pathology Could Improve Diagnosis and Treatment of Huntington’s Disease

News

Researchers have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington’s disease, and could be used to improve their diagnosis and treatment.

READ MORE

Testing Patients for Endothelial Cell Injury Could Help To Predict COVID-19 Severity

News

Researchers at Yale have found that injury to endothelial cells may be a key driver of COVID-19 severity and death. The discovery suggests that doctors could both test patients for endothelial cell injury, known as endotheliopathy, and mitigate it with drugs to improve patient outcomes.

READ MORE

SARS-CoV-2 Can Infect Heart Cells in a Lab Dish

News

A new study shows that SARS-CoV-2, the virus that causes COVID-19, can infect heart cells in a lab dish, indicating it may be possible for heart cells in COVID-19 patients to be directly infected by the virus.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE